Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'
Portfolio Pulse from Jelena Martinovic
Entourage Health Corp. reported a 9% YoY increase in Q1 revenue, positive EBITDA, and substantial growth. The company achieved a gross profit of CA$5.8 million and a gross margin of 45%. Despite a loss of CA$6.3 million, the company showed improved profitability and significant growth in its adult-use business.
May 28, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Entourage Health Corp. reported a 9% YoY increase in Q1 revenue, positive EBITDA, and substantial growth. The company achieved a gross profit of CA$5.8 million and a gross margin of 45%. Despite a loss of CA$6.3 million, the company showed improved profitability and significant growth in its adult-use business.
The positive financial results, including a 9% YoY increase in revenue and the first positive EBITDA, indicate strong performance and growth potential. This has already led to a 38.6% increase in share price, suggesting a positive short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100